Concepedia

Ku Lu

KL

Statistics

Publications

10

Citations

742

H-Index

10

Active since

1998

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Eli Lilly (United States)

Institut Clinique de la Souris

Ku Lu is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in life sciences, pharmacology, and diabetes mellitus.

Publications per year

1998–2019

10

Publications

10

Systemic pan-AMPK activator MK-8722 improves glucose homeostasis but induces cardiac hypertrophy

Robert W. Myers, Hong-Ping Guan, Juliann Ehrhart et al. · Science · 2017 · 344 citations

, , +17

Glucagon receptor antagonism induces increased cholesterol absorption

Hong-Ping Guan, Xiaodong Yang, Ku Lu et al. · Journal of Lipid Research · 2015 · 76 citations · Full text

, , +17

Discovery of MK-8722: A Systemic, Direct Pan-Activator of AMP-Activated Protein Kinase

Danqing Feng, Tesfaye Biftu, F. Anthony Romero et al. · ACS Medicinal Chemistry Letters · 2017 · 62 citations · Full text

, , +14

Nuclear DNA Content and Chromosome Numbers in Switchgrass

Ku Lu, Shawn M. Kaeppler, Kenneth P. Vogel et al. · Lincoln (University of Nebraska) · 1998 · 54 citations · Full text

, , +14

Dihydropyrrolopyrazole Transforming Growth Factor-β Type I Receptor Kinase Domain Inhibitors:  A Novel Benzimidazole Series with Selectivity versus Transforming Growth Factor-β Type II Receptor Kinase and Mixed Lineage Kinase-7

Hongyu Li, Yan Wang, Charles R. Heap et al. · Journal of Medicinal Chemistry · 2006 · 48 citations · Full text

, , +13

1–5 of 10